Drug intelligence / Profile preview

fermented cordyceps sinensis mycelia powder

Development stage
Phase 4
Lead developer
Jiangxi Jimin Kexin Pharmaceutical
Administration
Oral
01

Overview

Jinshuibao is a traditional Chinese medicine (TCM) whose active ingredient is fermented Cordyceps sinensis mycelia powder, also known as Cs-4. It is developed and manufactured by Jiangxi Jinshuibao Pharmaceutical, a subsidiary of Jemincare. It is considered a modern equivalent to wild Cordyceps sinensis, produced through a fermentation process. [2, 17] Jinshuibao is purported to have a wide range of benefits, including anti-inflammatory, antioxidant, and immunomodulatory effects. [2] In China, it is approved for conditions related to lung and kidney deficiencies, such as chronic bronchitis and chronic renal failure, and is also used for hyperlipidemia and liver cirrhosis. [8, 5] Clinical trials are investigating its use for radiation pneumonitis, recovery from COVID-19, and chronic kidney disease.

Brand names
JinshuibaoJinshuibao PianJinshuibao Jiao Nang金水宝
Other names
fermentative cordyceps fungus powder

Beyond the preview

Go deeper on fermented cordyceps sinensis mycelia powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fermented cordyceps sinensis mycelia powder.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call